Exosomal miR-133a-3p promotes the growth and metastasis of lung cancer cells following incomplete microwave ablation

References

• Thai AA, Solomon BJ, Sequist LV, et al. Lung cancer. Lancet. 2021;398(10299):535–554.
   PubMed Web of Science ®Google Scholar
• Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1–24.
   PubMed Web of Science ®Google Scholar
• Izzo F, Granata V, Grassi R, et al. Radiofrequency ablation and microwave ablation in liver tumors: an update. Oncologist. 2019;24:e990–e1005.
   PubMed Web of Science ®Google Scholar
• Sidoff L, Dupuy DE. Clinical experiences with microwave thermal ablation of lung malignancies. Int J Hyperthermia. 2017;33(1):25–33.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Nour-Eldin NA, Albrecht MH, et al. Thermal ablation of lung tumors: focus on microwave ablation. Rofo. 2017;189(9):828–843.
   PubMedGoogle Scholar
• Gaia S, Ciruolo M, Ribaldone DG, et al. Higher efficiency of percutaneous microwave (MWA) than radiofrequency ablation (RFA) in achieving complete response in cirrhotic patients with early hepatocellular carcinoma. Curr Oncol. 2021;28(2):1034–1044.
   PubMed Web of Science ®Google Scholar
• Cao B, Liu M, Wang L, et al. Remodelling of tumour microenvironment by microwave ablation potentiates immunotherapy of AXL-specific CAR T cells against non-small cell lung cancer. Nat Commun. 2022;13(1):6203.
   PubMed Web of Science ®Google Scholar
• Moussa AM, Ziv E, Solomon SB, et al. Microwave ablation in primary lung malignancies. Semin Intervent Radiol. 2019;36(4):326–333.
   PubMed Web of Science ®Google Scholar
• Rangamuwa K, Leong T, Weeden C, et al. Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors. Transl Lung Cancer Res. 2021;10(6):2842–2857.
   PubMed Web of Science ®Google Scholar
• Wang J, Hu L, Yang X, et al. A study of microwave ablation for small cell lung cancer. J Cancer Res Ther. 2022;18(2):399–404.
   PubMed Web of Science ®Google Scholar
• Healey TT, March BT, Baird G, et al. Microwave ablation for lung neoplasms: a retrospective analysis of long-term results. J Vasc Interv Radiol. 2017;28(2):206–211.
   PubMed Web of Science ®Google Scholar
• Sun Z, Shi K, Yang S, et al. Effect of exosomal miRNA on cancer biology and clinical applications. Mol Cancer. 2018;17(1):147.
   PubMed Web of Science ®Google Scholar
• Li I, Nabet BY. Exosomes in the tumor microenvironment as mediators of cancer therapy resistance. Mol Cancer. 2019;18(1):32.
   PubMedGoogle Scholar
• Xu R, Rai A, Chen M, et al. Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol. 2018;15(10):617–638.
   PubMed Web of Science ®Google Scholar
• Hu C, Meiners S, Lukas C, et al. Role of exosomal microRNAs in lung cancer biology and clinical applications. Cell Prolif. 2020;53(6):e12828.
   PubMed Web of Science ®Google Scholar
• Wu J, Shen Z. Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer. Cancer Med. 2020;9(19):6909–6922.
   PubMed Web of Science ®Google Scholar
• Shen Y, Katsaros D, Loo LW, et al. Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer. Oncotarget. 2015;6(11):8579–8592.
   PubMedGoogle Scholar
• Zhao M, Sun J, Zhao Z. TSGene: a web resource for tumor suppressor genes. Nucleic Acids Res. 2013;41(Database issue):D970–D976.
   PubMedGoogle Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:1–40.
   Web of Science ®Google Scholar
• Mao L, Li X, Gong S, et al. Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis. Cancer Gene Therapy. 2018;25:248–259.
   PubMed Web of Science ®Google Scholar
• Mashouri L, Yousefi H, Aref AR, et al. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18(1):75.
   PubMed Web of Science ®Google Scholar
• Munagala R, Aqil F, Gupta RC. Exosomal miRNAs as biomarkers of recurrent lung cancer. Tumour Biol. 2016;37(8):10703–10714.
   PubMedGoogle Scholar
• Munagala R, Aqil F, Taylor D, et al. Abstract 1947: tumor-derived circulatory exosomal miRNAs as biomarkers of recurrent lung tumors. Cancer Res. 2013;73:1947–1947.
   Google Scholar
• Matsumura T, Sugimachi K, Iinuma H, et al. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br J Cancer. 2015;113(2):275–281.
   PubMed Web of Science ®Google Scholar
• Sueta A, Yamamoto Y, Tomiguchi M, et al. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence. Oncotarget. 2017;8(41):69934–69944.
   PubMedGoogle Scholar
• Kanaoka R, Iinuma H, Dejima H, et al. Usefulness of plasma exosomal MicroRNA-451a as a noninvasive biomarker for early prediction of recurrence and prognosis of non-small cell lung cancer. Oncology. 2018;94(5):311–323.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhou J, Mei S, et al. Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7. J Cell Mol Med. 2017;21(6):1228–1236.
   PubMed Web of Science ®Google Scholar
• Cui H, Seubert B, Stahl E, et al. Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes. Oncogene. 2015;34(28):3640–3650.
   PubMed Web of Science ®Google Scholar
• Zhang X, Sai B, Wang F, et al. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Mol Cancer. 2019;18(1):40.
   PubMedGoogle Scholar
• Tan Y, Zhao L. miR-103 promotes hepatocellular carcinoma cell proliferation and migration in the simulation transition zone of RFA through PI3K/akt signaling pathway by targeting PTEN. Int J Clin Exp Path. 2020;13:473–479.
   PubMed Web of Science ®Google Scholar
• Hu X, Zhang F, Liu XR, et al. Efficacy and potential MicroRNA mechanism for computed tomography-guided percutaneous radiofrequency ablation of primary lung cancer and lung metastasis from liver cancer. Cell Physiol Biochem. 2014;33(5):1261–1271.
   PubMedGoogle Scholar
• Xu Y, Zhang L, Xia L, et al. MicroRNA-133a-3p suppresses malignant behavior of non-small cell lung cancer cells by negatively regulating ERBB2. Oncol Lett. 2021;21(6):457.
   PubMed Web of Science ®Google Scholar
• Karbasforooshan H, Roohbakhsh A, Karimi G. SIRT1 and microRNAs: the role in breast, lung and prostate cancers. Exp Cell Res. 2018;367(1):1–6.
   PubMed Web of Science ®Google Scholar
• Li X, Jiang Z, Li X, et al. SIRT1 overexpression protects non-small cell lung cancer cells against osteopontin-induced epithelial-mesenchymal transition by suppressing NF-κB signaling. Onco Targets Ther. 2018;11:1157–1171.
   PubMed Web of Science ®Google Scholar
• Costa-Machado LF, Martín-Hernández R, Sanchez-Luengo M, et al. Sirt1 protects from K-Ras-driven lung carcinogenesis. EMBO Rep. 2018;19(9):1–14.
   Google Scholar